Fig. 8
From: Syringin exerts anti-breast cancer effects through PI3K-AKT and EGFR-RAS-RAF pathways
Syringin decreased the migration of MCF-7 cells (A) and MDA-MB-231 cells (B). C The expression of PIK3CA, p-PIK3CA, p-ATK, p65, p-p65, and COX-2. D Syringin decreased the expression of p-PIK3CA, p-ATK, p-p65, and COX-2, but didn't change the expression of PIK3CA and p65 in MCF-7 cells. E Syringin decreased the expression of p-PIK3CA, p-ATK, p-p65, and COX-2, but didn't change the expression of PIK3CA and p65 in MDA-MB-231 cells. *P < 0.05 and **P < 0.01